Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis (Q38189266)

30 August 2017

0 references

Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis (English)

1 reference

colorectal adenocarcinoma

30 August 2017

1 reference

1 reference

1 reference

Yu-Jie Zeng

1

1 reference

30 August 2017

Wei Lai

2

1 reference

30 August 2017

Lu Liu

3

1 reference

30 August 2017

Heng Wu

4

1 reference

30 August 2017

Xing-Xi Luo

5

1 reference

30 August 2017

Jie Wang

6

1 reference

30 August 2017

Zhong-Hua Chu

7

1 reference

30 August 2017

publication date

19 February 2014

1 reference

Journal of Gastrointestinal Surgery

30 August 2017

published in

1 reference

30 August 2017

volume

18

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

968-976

1 reference

Neuroendocrine differentiation in castration-resistant prostate cancer: a systematic diagnostic attempt.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Lung tumours with neuroendocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Heterogeneous expression of neuroendocrine marker proteins in human undifferentiated carcinoma of the colon and rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Chromogranin positive cells in colorectal carcinoma and transitional mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Technical note: The risk ratio, an alternative to the odds ratio for estimating the association between multiple risk factors and a dichotomous outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2480-X

Correlation between chromogranin-A expression and pathological variables in human colon carcinoma

21 January 2018

1 reference

12 December 2020

Neuroendocrine differentiation and prognosis in breast adenocarcinoma

1 reference

12 December 2020

The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas

1 reference

12 December 2020

Prevalence and Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas

1 reference

12 December 2020

Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance

1 reference

12 December 2020

The endocrine cells of the gastrointestinal tract. The normal endocrine cells and their hyperplasias. Part I.

1 reference

12 December 2020

Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis

1 reference

12 December 2020

Endocrine cells and prognosis in patients with colorectal carcinoma

1 reference

12 December 2020

Neuroendocrine differentiation in "poorly differentiated" colon carcinomas

1 reference

12 December 2020

The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon.

1 reference

12 December 2020

10.1007/S11605-014-2480-X

Identifiers

DOI

1 reference

30 August 2017

1 reference